The COVID-19 pandemic has been a stress test for the entire US Food and Drug Administration, a panel of high-level regulators reiterated at a recent industry conference, which included one FDAer who went into detail about some specific impacts the pandemic has had on device and diagnostic regulation.
“This particular public health emergency has had a huge impact on the medical device ecosystem as a whole, and the FDA’s medical device program has continued to adjust and adapt,”...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?